Researchers Probe New Territory in Treating Patients with Lung Cancer during COVID-19 Pandemic Press Briefing with International Researchers Explores this Question at IASLC 2020 World Conference on Lung Cancer Singapore To view a recording of the press briefing, visit:...

Lung Cancer Care and Research Not Immune to Socioeconomic, Ethnic, Racial, and Gender-related Factors that Create Disparities SINGAPORE, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Several leading international lung cancer researchers at a press today presented compelling new data revealing that factors of race, gender, sexual...

Sotorasib Provides Durable Clinical Benefit for Patients with NSCLC and KRAS Mutations SINGAPORE, Jan. 28, 2021 (GLOBE NEWSWIRE) -- In the phase II CodeBreak 100 trial, sotorasib provided durable clinical benefit with a favorable safety profile in patients with pretreated non-small...

Lung cancer researchers present new clinical trial data at International Association for the Study of Lung Cancer World Conference on Lung Cancer Virtual Presidential Symposium DENVER, Aug. 08, 2020 (GLOBE NEWSWIRE) -- The combination of first-line nivolumab and ipilimumab demonstrated an improvement of overall survival for patients with unresectable malignant pleural...